Altimmune Stock

Altimmune Long-term Debt

The Long-Term Debt of Altimmune (ALT) as of Aug 22, 2026 is 34.29 M USD.

Long-term Debt

34.29 MUSD

Last updated:

Long-Term Debt of Altimmune is 2026 34.29 M USD. Long-Term Debt of Altimmune was 2025 0.00 USD. It decreases by % higher compared to the previous year.

The Altimmune Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2015
545,232.00 USD
Jan 1, 2016
525,950.00 USD
Jan 1, 2017
4.57 M USD
Jan 1, 2018
1.85 M USD
Jan 1, 2019
1.86 M USD
Jan 1, 2020
1.83 M USD
Jan 1, 2021
1.45 M USD
Jan 1, 2025
34.29 M USD
The Altimmune Long-term Debt history
YEARLong-term DebtYoY
34.29 MUSD+2,257.79%
1.45 MUSD-20.47%
1.83 MUSD-1.95%
1.86 MUSD+0.69%
1.85 MUSD-59.51%
4.57 MUSD+769.76%
525,950.00USD-3.54%
545,232.00USD
0.00USD
Access this data via the Eulerpool API

Altimmune Stock analysis

What does Altimmune do? Altimmune Inc is a biopharmaceutical company specializing in the development of immunotherapies. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland, USA. Altimmune is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Altimmune stock

Long-Term Debt of Altimmune is 34.29 M USD in 2026.

On Eulerpool you can find the complete historical development of Long-Term Debt Altimmune since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Altimmune historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Altimmune

All Key Metrics — Altimmune